Ramírez-Segura EH, Ruiz-Chow ÁA

Language: Spanish
References: 27
Page: 123-132
PDF size: 154.57 Kb.

ABSTRACT

Electroconvulsive therapy is a short, efficient, secure and controversial treatment of various neuropsychiatric conditions, their use has increased in the United States of America, performing approximately 100,000 procedures a year. It was described in 1938 and carried out without anesthesia for at least 30 years. Currently in the United States of America the number of electroconvulsive therapy procedures under general anesthesia, far exceeds the number of coronary revascularizations, appendectomies and wall plasty. Anesthetic techniques have undergone major developments to improve conditions and safety of modern electroconvulsive therapy. The electroconvulsive therapy is a complex procedure that requires a well-prepared professional staff, the electroconvulsive therapy treatment group must function as a team and is usually made by a psychiatrist (trained in electroconvulsive therapy), an anesthesiologist (with training in neuro-anesthesiology), nurses with experience in electroconvulsive therapy room and in the PACU. To improve the outcome of patients undergoing electroconvulsive therapy, the anesthesiologist must have a thorough knowledge of the physiological effects of electroconvulsive therapy, the pharmacology of the drugs administered, their effect on the response of electroconvulsive therapy and how to reduce the side effects related to electroconvulsive therapy.

REFERENCES

1. American Psychiatric Association. The practice of electroconvulsive therapy. Recommendations for treatment, training, and privileging: a task force report of APA. Washington, DC, American Psychiatric Association 2002.

2. Bundy B, Hewer W, et al. Influence of anesthetic drug and concurrent psychiatric medication on seizure adecuacy during electronconvulsive therapy. J Clin Psychiatry 2010;71:775-777.

3. Aguilar GJ. PAC-Psiquiatria-4. Libro 4 Terapia electroconvulsiva. México D.F. Ed. Intersistemas, S.A. de C.V. 2003:217-20.

4. Avramov M, Stool L, White P, Huasain M. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy. J Clinical Anesthesia 1998;10:394-400.

5. Ring B, Parnass S, Shulman R. Cardiogenic shock after electroconvulsive therapy. Anesthesiology 1996;84:1511-1513.

6. NOM-006-SSA3-2011, Para la práctica de la anestesiología. Diario Oficial de la Federación. México.

7. Park KW. Preoperative cardiology consultation. Anesth 2003;98:754-762.

8. Ciraulo D, et al. Drug interactions in psychiatry. Philadelphia, PA. Lippincott, Williams and Wilkins. 2006:376-97.

9. Folk JW, Kellner CH, Beale MD. Anesthesia for electroconvulsive therapy: a review. J. ETC 2000;16:157-70.

10. Mayur PM, Shree RS, Gangadhar BN, et al. Atropine premedication and the cardiovascular response to electroconvulsive therapy. Br J Anaesth 1998;81:466-467.

11. Boylan L, Haskett R. et al. Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ETC 2000;16:3-18.

12. Stone DJ, Gal TJ. Airway management, In: Anesthesia, 5th ed. Miller RD, ed. Churchill Livingstone, 2000:1414-51.

13. Geretsegger C, Rochowanski E, Kartnig C, Unterrainer AF. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. J ECT 1998;14:28-35.

14. Smith D, Angst M, Brock-Utne J, De Battista C. Seizure duration with ramifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. Acta Anaesthesiol Scand 2003;47:1064-1066.

15. Dinwiddie S, Glick D, Goldman M. The effect of propofol-remifentanil anesthesia on selected seizure quality indices in electroconvulsive therapy. Brain Stimulation 2012;5:402-407.

16. Luo J, Wei K, Zhang J, Liu Y. Propofol interacts with stimulus intensities of electroconvulsive shock to regulate behavior and hippocampal BDNF in a rat model of depression. Psychiatry Res 2012;198:300-306.

17. Warnell R., Swartz C., Thomson A. Propofol interruption of ECT seizure to reduce side-effects: A pilot study. Psychiatry Res 2010;175(1-2):184-5.

18. White PF. Rapacuronium: why did it fail as a replacement for succinylcholine? Br J Anaesth 2002;88:1-3.

19. Van den Broek WW, Leentjens AF, Mulder PG, et al. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth 1999;83:271-274.

20. Wajima Z, Yoshikawa T, Ogura A, et al. The effects of diltiazem on hemodynamics and seizure duration during electroconvulsive therapy. Anesth Analg 2001;92:1327-1330.

21. Fu W, Stool LA, White PF, Husain MM. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Anesth Analg 1998;86:1127-1130.

22. Fu W, White PF. Dexmedetomidine failed to block the acute hyperdynamic response to electroconvulsive therapy. Anesthesiology 1999;90:422-424.

23. Wajima Z, Yoshikawa T, Ogura A, et al. Intravenosus verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg 2002;95:400-402.

24. Liu S, Modell JH. Anesthetic management for patients with postpolio syndrome receiving electroconvulsive therapy. Anesthesiology 2001;95:799-801.

25. Kadar AG, Ing CH, White PF, et al. Anesthesia for electroconvulsive therapy in obese patients. Anesth Analg 2002;94:360-361.

26. Nishihara F, Saito S. Pre-ictal bispectral index has a positive correlation with seizure duration during electroconvulsive therapy. Anesth Analg 2002;94:1249-1252.

27. White PF, Rawal S. Can the bispectral index be used to predict seizure time and awakening after electroconvulsive therapy? Anesth Analg 2003;96:1636-1639.